Provided are methods of treatment for nicotine dependency and nicotine withdrawal effects (e.g., a method of smoking cessation) in a human in need thereof comprising administering to the human an effective amount of (1R,5S)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, in free or pharmaceutically acceptable salt form.
